Pharmacokinetics of meptazinol in man following repeated intramuscular administration
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 23 (6) , 535-538
- https://doi.org/10.1007/bf00637502
Abstract
A study was performed in 6 healthy volunteers to determine whether 50 mg intramuscular doses of meptazinol repeated four hourly for 24 h would lead to accumulation of the drug. The first dose of meptazinol was rapidly absorbed with a subsequent mean (± SD) elimination half-life of 1.6±0.33 h. This value was unaffected by the administration of intermediate doses. There was no significant accumulation of the drug; 95% of the steady-state plasma concentration was achieved after a mean (± SD) of 1.9±0.39 and 99% after a mean (± SD) of 2.9±0.63 doses. These findings are consistent with the theoretical prediction for a rapidly absorbed drug with a plasma elimination half-life of 1.6 h. No clinically relevant changes were seen in pulse blood pressure, haematological or biochemical screens. Reported side effects were of a subjective and minor nature.This publication has 7 references indexed in Scilit:
- Double‐blind comparison of meptazinol and pethidine in labourBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Determination of meptazinol in plasma by high-performance liquid chromatography with fluorescence detectionThe Analyst, 1981
- A DOUBLE-BLIND COMPARISON OF MEPTAZINOL WITH PETHIDINE IN POSTOPERATIVE PAINBritish Journal of Anaesthesia, 1980
- CLINICAL EVALUATION OF MEPTAZINOL, A NEW ANALGESIC, IN POSTOPERATIVE PAINBritish Journal of Anaesthesia, 1976
- Pharmacokinetics and Metabolism of the New Analgesic Meptazinol in Rats and Patas MonkeysXenobiotica, 1976
- Meptazinol (Wy 22811), a new analgesic: Preliminary pharmacokinetic dataCurrent Medical Research and Opinion, 1975
- An Algorithm for Least-Squares Estimation of Nonlinear ParametersJournal of the Society for Industrial and Applied Mathematics, 1963